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function (Goldstein and de Jong, 1974; Theroux et al., 1976; Heyndrickx et al., 1978) . On the other hand, the effect of the state of myocardial contractility on coronary blood flow has received less attention. Systolic contraction has been shown to produce compression of the coronary vessels, thereby increasing their resistance to blood flow (Sabiston and Gregg, 1957; Kirk and Honig, 1964; Armour and Randall, 1971) . This resistance to flow, which results from compression of the coronary vessels, is termed extravascular resistance, in contradistinction to the vascular resistance. The latter reflects changes of vessel diameter that result from coronary vasomotor tone.
The purpose of this study was to evaluate the extent to which changes of myocardial contractility can affect coronary extravascular resistance and the distribution of blood flow within the myocardium. The experimental model used permits augmentation or reduction of regional myocardial contractile performance without affecting left ventricular pressure (L'Abbate et al., 1978) .
We proposed to determine if extravascular resistance is affected by a mechanical action of the contracting fibers on the intramural vessels. Regional variations of contractile performance may be a factor involved in coronary extravascular resistance and ultimately may participate in the regulation of local perfusion.
Methods
Ten adult mongrel dogs, weighing 25-40 kg, were anesthetized with sodium pentobarbital (25 mg/kg, iv) and ventilated with a Harvard respirator. A midsternal thoracotomy was performed and the pericardium opened. Ten thousand to 20,000 U of \J(/ l CORONARY heparin were injected intravenously. The middle third of the left anterior descending coronary artery was isolated and cannulated with a double lumen cannula and perfused with blood withdrawn from the femoral artery by a constant flow pump (Sarns model 6050) (Fig. 1 ). An air chamber (Windkessel) was interposed between the pump and the cannula to ensure a physiological flow pattern in the coronary segment (L'Abbate et al., 1978) . A similar pump was used to infuse adenosine (0.2 mg/100 ml of coronary blood flow) continuously into the main perfusion line to maintain a state of full vasodilation. An infusion/withdrawal pump (Harvard Apparatus model 600-900) was used for drug administration. A catheter-tip micromanometer (Millar Micro-Tip model PC-360) was advanced to the left ventricle from the right common carotid artery for the measurement of left ventricular pressure, whereas aortic and coronary pressures were recorded with Statham P23Db pressure transducers. The coronary pressure in the peripheral portion of the perfused vessel was measured through the smaller lumen of the coronary cannula.
FEMORAL ARTIRT
• LOOO RESERVOIR FIGURE 1 Schematic illustration of the perfusion system of the left anterior descending coronary artery (LAD). The shaded area corresponds to the region perfused by the cannulated artery as it appears on the external surface of the heart and in a transverse section. VOL. 45, No. 5, NOVEMBER 1979 By varying the rate of the pump, we continuously adjusted the flow in the coronary artery to maintain a peripheral coronary diastolic pressure superimposable on the aortic diastolic pressure. This technique caused the flow pumped into the coronary cannula to be identical to the flow that the perfused area would receive naturally for a given level of aortic pressure and coronary resistance (L'Abbate et al., 1978) . Thus, any change in the coronary flow directly reflected a change of coronary resistance. An electromagnetic flow transducer (Biotronex Lab., Inc.) was placed in series with the coronary cannula. Frequent measurement of pH, the partial pressure of oxygen in arterial blood, and hematocrit were made throughout the study to ensure that they were in the normal range. The perfused area, identified by an injection of dye in the coronary cannula at the end of the study, weighed an average of 33 g and corresponded to 27-34% of the entire left ventricle.
Regional Function
For the measurement of the regional myocardial function, a pair of ultrasonic crystals (Schuessler) was placed in the myocardium of the perfused area in seven dogs Sasayama et al., 1976) . The subendocardial crystal was introduced at an angle of 45° so that the myocardium between the two crystals would not be injured. In implanting the subendocardial crystal, a small tract was created with an 18-gauge needle. The crystal then was inserted into the myocardium at a depth of about 10 mm. The epicardial transducer was sutured in direct alignment with the subendocardial crystal by observation of the electronic signal on an oscilloscope. During each experiment, the measured transit time was calibrated against a standard crystal-controlled oscillator and was converted to distance by use of a velocity of sound of 1.5 mm/fisec. At a constant room temperature, the drift of the instrument due to the electronics is minimal, i.e., less than 0.01 mm in 6 hours, and the frequency response is flat to 60 Hz. The wall thickness coincident with the left ventricular end-diastolic pressure was defined as diastolic wall thickness, and the wall thickness coincident with the aortic incisura was defined as systolic wall thickness.
Regional Blood Flow
The total blood flow to the perfused area was determined from the calibrated flow pumped through the cannula. The pump was calibrated at the end of each experiment with a stopwatch and a graduated cylinder using the dog's blood. The electromagnetic flow transducer, which was calibrated separately, served as a check on the accuracy of the measurement of coronary flow. In nine dogs, the distribution of myocardial blood flow was assessed by injecting into the perfusion line microspheres, 9 ± 1 jim in diameter, labeled with y-emitting radio-nuclides, 125 I, H5 Ce, ^Sr, and ^Nb (3M Company) (Domenech et al., 1969; Buckberg et al., 1971) . A glass ampul, with internal septi interposed between the injection site and the coronary cannula, resulted in turbulent flow downstream to the site of injection of the microspheres into the system. This ensured a thorough mixing of the microspheres with the blood before their distribution to the perfused myocardium (Fig. 1) . The microspheres were obtained as 1.0 mCi of each nuclide in 20 ml of 10% dextran-40 and diluted so that 0.4 ml, the volume injected, contained approximately 80,000 microspheres. Injection of this amount of microspheres resulted in no appreciable change of coronary flow, coronary resistance, or regional function. Prior to injection, microspheres were mixed by agitation for at least 15 minutes in an ultrasonic bath and a vortex agitator. Each of the four different isotopes was injected in random order in each dog.
After completion of the study, the perfused area was stained with Evans blue dye. The dogs were killed with a lethal dose of pentobarbital, and the hearts were removed and fixed in 10% buffered formalin. The left ventricle then was dissected and sectioned in six transverse rings that were parallel to the mitral valve. Each ring was 1-1.5 cm thick. All of the rings that showed any stained tissue were cut into eight wedges. The wedges that were uniformly and completely stained corresponded to the central part of the perfused area. These wedges were cut in external, middle, and internal thirds. The external and internal thirds were used for the calculation of the endocardiakepicardial ratio (Fig.  1) . The stained portion of partially stained wedges was dissected away from unstained tissue. All of the stained samples then were weighed and counted with an autogamma scintillation spectrometer (Packard). Window settings corresponding to the peak energies emitted by each radioactive nuclide were used. The activities recorded in each energy window, the weight of the corresponding sample, and the total flow during each injection were entered into a digital computer that was programmed to correct for background activity and energy crossover. The corrected flow was computed and expressed in milliliters per minute per gram of tissue, according to the equation: sample blood flow -(total flow/total counts) x sample counts.
The ratio of coronary diastolic pressure to left ventricular systolic pressure was calculated. The transmural distribution of coronary blood flow, expressed as the endocardial:epicardial ratio, has been related to this ratio (L'Abbate et al., 1978) .
Protocol
After attaining maximal coronary vasodilation by the intracoronary administration of adenosine, the first dose of microspheres was injected. The achievement and persistence of maximal coronary vasodilation throughout the study was shown by the absence of any change in coronary pressure following 15 seconds of coronary occlusion. This was checked before each injection of microspheres. After the control injection of microspheres, lidocaine was infused into the coronary perfusion line at a rate of 38 /ig/min. A duration of infusion of about 60 seconds was necessary before a definite reduction of systolic wall thickening occurred. The infusion was continued and, after 3-4 minutes, a steady state appeared to be present. The second injection of microspheres then was performed. After the second injection, the infusion of lidocaine was discontinued, and the perfused area was allowed time to recover. Thirty minutes after the second injection, a third "control" set of microspheres was administered, and an infusion of isoproterenol, 1.5 jUg/min, was started. After 40-50 seconds, augmented systolic wall thickening was observed. Again, a period of 4-5 minutes was allowed to establish a steady state, and then the fourth and last injection of microspheres was made. Standard lead 2 of the electrocardiogram, left ventricular pressure, aortic pressure, coronary pressure, coronary flow, and left ventricular wall thickness were recorded continuously on an Electronics for Medicine VR12 photographic recorder. The effects of the infusions of lidocaine and isoproterenol on coronary hemodynamics and myocardial perfusion were evaluated by comparing the data obtained during the infusion of each drug with its preceding control measurement. The data were analyzed by the paired Student's t-test.
Results

Regional Function
The effects of the infusions of lidocaine and isoproterenol on regional function are summarized in Table 1 . In the absence of any pharmacological intervention, the left ventricular wall thickness started to increase at the end of the left ventricular isovolumic contraction. Wall thickening appeared to progress throughout left ventricular ejection and to peak in early diastole. Then, progressive thinning of the wall was observed during the remainder of diastole and atrial systole (Fig. 2) .
The diastolic and systolic values of the left ven- tricular wall thickness were 10.1 ± 0.8 mm and 11.8 ± 0.8 mm, respectively, prior to the administration of lidocaine, and 10.0 ± 0.8 mm and 11.8 ± 0.6 mm prior to the administration of isoproterenol. During these control periods, the systolic wall thickening was 18% and 17%, respectively (Table 1) . The intracoronary infusion of lidocaine resulted in a complete absence of contraction of the perfused area (Fig. 2) . No systolic thickening was evident, and in some instances, a thinning was observed. Middiastolic thickening was observed coincident with peak coronary flow.
Direct observation of the area infused by lidocaine showed an obvious systolic bulging. The intracoronary administration of isoproterenol re- VOL. 45, No. 5, NOVEMBER 1979 suited in a small, but significant increase of both end-diastolic wall thickness (from 10.0 ± 0.8 mm to 10.3 ± 0.8 mm), and end-systolic wall thickness (from 11.8 ± 0.6 mm to 12.6 ± 0.9 mm). Systolic wall thickening during isoproterenol increased from an average of 17% to 22%, and approximately twothirds of thickening occurred during early systole (Fig. 3 ).
Systemic and Coronary Hemodynamics
Heart rate, aortic pressure, left ventricular pressure, and the maximal rate of change of left ventricular pressure (max dp/dt) did not change significantly during either regional lidocaine or regional isoproterenol infusion (Table 2) .
Because coronary perfusion pressure during the entire experiment was maintained carefully by varying coronary blood flow, changes of coronary blood flow directly reflected changes of coronary resistance. Administration of lidocaine resulted in a reduction of coronary resistance, so that a 30% increase of coronary blood flow was required to maintain the coronary peripheral pressure at the level of aortic pressure (Table 2, Fig. 2) .
During the administration of isoproterenol, a 36% reduction of coronary flow was necessary to maintain the coronary peripheral pressure at the level of aortic diastolic pressure (Table 2, Fig. 3 ). This significant reduction of coronary blood flow was disproportionate in relation to the insignificant reduction of coronary diastolic pressure (8 mm Hg). Therefore, the reduced flow primarily resulted from an increased coronary resistance. Isoproterenol produced an increased pulse pressure in the peripheral coronary tracing, and the coronary flow waveform showed a wider excursion (Fig. 3 ).
Transmural Distribution of Coronary Blood Flow
The effects of lidocaine and isoproterenol on the transmural distribution of coronary blood flow are summarized in Table 3 . Both interventions affected the perfusion of the inner layers of the left ventricular wall more than the outer layers. Lidocaine caused a 48% increase of the subendocardial flow and a 23% increase of the subepicardial flow. This resulted in an increase of the endocardial:epicardial ratio from 1.02 ± 0.07 to 1.28 ± 0.07. Isoproterenol caused a 43% reduction of subendocardial perfusion and a 22% reduction of subepicardial perfusion. This resulted in a reduction of the endocardial:epicardial ratio from 1.08 ± 0.08 to 0.75 ± 0.07. These changes in the transmural distribution of coronary blood flow were not associated with changes of the coronary diastolic pressure:ventricular systolic pressure ratio or other predictors of the endocardial:epicardial ratio. Thus, these changes expressed the mechanical effects of changes of local contractile performance.
The comprehensive relation between regional contractile performance and myocardial perfusion Results are expressed as mean ± SE. LVEDP = left ventricular end-diastolic pressure; LV dp/dt -peak positive first derivative of left ventricular pressure. • P < 0.02; f P < 0.01; %P< 0.001. 
Control Lidocaine
Control Isoproterenol 6.2 ± 0.16 9.3 ± 0.6* 6.6 ± 0.9 3.7 ± 0.7* 6.1 ± 0.5 7.5 ± 0.6f 6.1 ± 0.6 4.8 ± 0.7* 1.02 ± 0.07 1.28 ± 0.07* 1.08 ± 0.07 0.75 ± 0.07f 0.78 ± 0.02 0.76 ± 0.01 0.75 ± 0.06 0.73 ± 0.07
Results are expressed as mean ± SE. • P < 0.001; t P < 0.01; $ P < 0.02. is shown in Figure 4 . Augmentations or reductions of contractile performance (as indicated by changes of systolic wall thickening) prominently affected coronary blood flow and its transmural distribution.
Discussion
In this study, the region perfused by the cannulated anterior descending coronary artery was approximately one-third the left ventricular mass; only a limited portion of the heart was affected by drug interventions. Therefore, the local administration of drugs resulted in no changes of global left ventricular performance, as indicated by the constancy of aortic pressure, left ventricular pressure, the rate of change of left ventricular pressure, and heart rate. The stability of these parameters during drug interventions indicates that the observed changes of coronary blood flow and transmural distribution of coronary flow were not due to these parameters or other factors that are known to relate to coronary flow distribution. Specifically, the observed changes did not result from alterations of the coronary diastolic pressure, the ratio of coronary diastolic pressure to left ventricular systolic pressure, or the ratio of the diastolic pressure time index to the systolic pressure time index (Cobb et al., 1974; Hoffman, 1978; Klassen et al., 1977; L'Abbate et al., 1974) . The studies were conducted during maximal pharmacological vasodilation to preclude changes of vasomotor tone as a factor in our results. In addition, coronary flow exceeded any possible metabolic requirements of the myocardium. Thus, metabolic or vasomotor effects did not influence the results.
Wall thickening consistently appeared to be prolonged beyond the end of left ventricular ejection. This can be related to the high level of coronary flow obtained in this study. Coronary vasodilation can lead to early diastolic wall thickening, perhaps related to hyperemia. Wall thickness tracings observed by others during reactive hyperemia closely resembled the pattern that we observed in this study (Heyndrickx et al., 1978) .
The middiastolic thickening observed during lidocaine infusion also could be related to coronary blood flow. Wall thickening was coincident with the diastolic peak of coronary flow and can be related to the cyclic change of the volume of blood contained in the affected segment. This diastolic wall "thickening" was not included in the measurement of systolic and diastolic wall thickness, because reported measurements were made coincidently with the aortic incisura and the left ventricular enddiastolic pressure.
Coronary Resistance and Regional Contractile Performance
Whenever vessels are dilated maximally, as in this study, following the administration of adenosine, or in ischemic regions, flow is thought to be dependent on perfusion pressure. Therefore, flow should remain unchanged if the perfusion pressure is unchanged (Hoffman, 1978) . In our experiments, however, we observed consistently major changes of coronary flow while maintaining a steady perfusion pressure. These studies were performed at a time when the coronary arteries were dilated maximally, and at a time when coronary reserve (based FIGURE 4 Effects of regional wall function, indicated by the percent change of wall thickness during systole (%& Wth), on local myocardial perfusion. Regional coronary flow (left) and the endocardial:epicardial ratio (ENDO/EPI) (right) varied inversely with regional function.
-10 0 10 20 30 . 45, No. 5, NOVEMBER 1979 on the ability of the coronary vessels to dilate) was exhausted (Bache and Cobb, 1977) . Nevertheless, wide fluctuations, including augmentations of regional coronary flow, occurred with local variations of contractile performance. In the absence of significant changes of the perfusion pressure, these changes of flow must be attributed primarily to changes in coronary extravascular resistance. A reduction of the coronary extravascular resistance has been reported in a similar experimental model during cardiac arrest (Snyder et al., 1975) . It was concluded from those studies that only a minor component of coronary extravascular resistance was due to myocardial contraction. These investigators believed that the major passive component of extravascular resistance was due to stresses in equilibrium with ventricular pressure. In our study, using an infusion of lidocaine directly into the coronary artery, we obtained a reduction of coronary resistance similar to that observed during vagal arrest (Snyder et al., 1975) . In addition, during an infusion of isoproterenol, we observed an augmentation of coronary resistance of a similar magnitude. Therefore, our study clearly indicates that changes of extravascular resistance can result in wide fluctuations of coronary flow, and localized contractile performance is the major contributing factor to coronary extravascular resistance.
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Transmural Distribution of the Coronary Blood Flow
At maximal coronary vasodilation, we observed a uniform transmural distribution of coronary blood flow, in agreement with observations by others . To explore possible changes in the transmural distribution of coronary blood flow that may result from changes in coronary extravascular resistance associated with alterations of regional myocardial performance, we measured regional myocardial blood flow in the subendocardial layers and in the subepicardial layers. Flow to the inner and outer layers of the myocardium were shown to be related inversely to changes of local contractile performance, and the inner layers are more prominently affected than the outer layers. Thus, prominent variations of the transmural distribution of coronary blood flow occurred in the absence of any change of the parameters that are commonly thought to affect the endocardiakepicardial distribution of flow. Such changes also occurred in the presence of a normal and unchanging left ventricular intracavitary pressure. This indicates that changes of local contractility affect the distribution of coronary flow by a direct mechanical action and not by changes of radial stress secondary to changes of the left ventricular intracavitary pressure.
The decrease in contraction provoked by a local infusion of lidocaine resulted in a regional dyskinesis and, hence, in an increase of the radius of the involved segment. This would cause an increased radial stress on the involved area and an increased compression on the coronary vessels. The converse would happen when local contractile performance is enhanced by isoproterenol if the local radius were reduced. Consequently, even without a change of left ventricular pressure, a local change of dimension would be expected to change the local wall tension, based upon the law of Laplace. Therefore, in the presence of either an increased or decreased local contractile performance, the associated changes of wall stress would lead to an underestimation of the changes of coronary extravascular resistance that we observed.
In a normally perfused cardiovascular bed, the effect of contraction on coronary flow is balanced by the coronary vasomotor tone. Coronary vasomotor tone is affected by myocardial oxygen consumption, which in turn is affected by contractility. In an ischemic and, hence, maximally dilated coronary vascular bed, our observations may explain the beneficial or detrimental effects on myocardial perfusion of various drugs that affect myocardial performance (Theroux et al., 1976; Vatner et al., 1976; Buckberg and Ross, 1973) . The role of regional contractility as a determinant of coronary blood flow and the transmural distribution of flow is more prominent in situations in which coronary vascular reserve is limited. When coronary perfusion is lowered progressively, maximal coronary vasodilation is reached earlier in the subendocardial vessels (Hoffman, 1978) . Considering this, and the fact that regional contractility has a more prominent effect on subendocardial flow, we conclude that any prediction of the transmural distribution of coronary blood flow should consider the local contractile state.
